Haisco Pharmaceutical Group Co (SZSE:002653) Long-Term Debt : ¥938 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Haisco Pharmaceutical Group Co Long-Term Debt?

Haisco Pharmaceutical Group Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥938 Mil.

Haisco Pharmaceutical Group Co's quarterly Long-Term Debt increased from Sep. 2023 (¥723 Mil) to Dec. 2023 (¥855 Mil) and increased from Dec. 2023 (¥855 Mil) to Mar. 2024 (¥938 Mil).

Haisco Pharmaceutical Group Co's annual Long-Term Debt increased from Dec. 2021 (¥452 Mil) to Dec. 2022 (¥1,311 Mil) but then declined from Dec. 2022 (¥1,311 Mil) to Dec. 2023 (¥855 Mil).

Haisco Pharmaceutical Group Co Long-Term Debt Historical Data

The historical data trend for Haisco Pharmaceutical Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haisco Pharmaceutical Group Co Long-Term Debt Chart

Haisco Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

79.90

334.90

452.41

1,311.46

854.68

Haisco Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															946.99	793.09	722.59	854.68	937.94

Haisco Pharmaceutical Group Co (SZSE:002653) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Haisco Pharmaceutical Group Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Haisco Pharmaceutical Group Co (SZSE:002653) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Haisco Pharmaceutical Group Co Ltd (SZSE:002653) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 17, Sanxiang Avenue, Shannan District, Tibet Autonomous Region, Zetang, CHN, 856000

Website

http://www.haisco.com

Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.

Executives

Fan Xiu Lian	Directors, executives
Zheng Wei	Directors, executives
Wang Meng	Secretary Dong
Wang Jun Min	Directors, executives
Deng Xiang	Directors, executives
Liu Han Bing	Supervisors
Zhang Xiao Xu	Supervisors
Tan Hong	Executives
Shen Ping	Director
Liang Yong	Supervisors
Chen Long	Independent director
Duan Qing Liang	Supervisors

Haisco Pharmaceutical Group Co (SZSE:002653) Headlines

No Headlines